Relationship between hypoxia and response to antiangiogenic therapy in metastatic colorectal cancer

著者: Ulivi, Paola, Marisi, Giorgia, Passardi, Alessandro
出版年 Oncotarget (2016)

Special Issue on Basic and Translational Research in Colorectal Cancer

著者: Ulivi, Paola, Scarpi, Emanuela, Passardi, Alessandro
出版年 Int J Mol Sci (2019)

Molecular and Translational Research on Colorectal Cancer

著者: Passardi, Alessandro, Scarpi, Emanuela, Ulivi, Paola
出版年 Int J Mol Sci (2020)

Special Issue on Molecular and Translational Research on Colorectal Cancer 2.0

著者: Passardi, Alessandro, Scarpi, Emanuela, Ulivi, Paola
出版年 Int J Mol Sci (2021)

Immune Checkpoints as a Target for Colorectal Cancer Treatment

著者: Passardi, Alessandro, Canale, Matteo, Valgiusti, Martina, Ulivi, Paola
出版年 Int J Mol Sci (2017)

Discrepancies between VEGF −1154 G>A Polymorphism Analysis Performed in Peripheral Blood Samples and FFPE Tissue

著者: Marisi, Giorgia, Passardi, Alessandro, Calistri, Daniele, Zoli, Wainer, Amadori, Dino, Ulivi, Paola
出版事項 2014

Detection of KRAS mutant alleles in circulating cell-free tumor DNA in colorectal cancer patients resistant to cetuximab

著者: Del Re, Marzia, Ulivi, Paola, Passardi, Alessandro, Zoli, Wainer, Danesi, Romano, Amadori, Dino
出版事項 2014

Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?

著者: Molinari, Chiara, Marisi, Giorgia, Passardi, Alessandro, Matteucci, Laura, De Maio, Giulia, Ulivi, Paola
出版年 Int J Mol Sci (2018)

EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab

著者: CHIADINI, ELISA, SCARPI, EMANUELA, PASSARDI, ALESSANDRO, CALISTRI, DANIELE, VALGIUSTI, MARTINA, SARAGONI, LUCA, ZOLI, WAINER, AMADORI, DINO, ULIVI, PAOLA
出版年 Oncol Lett (2015)

Instability of Non-Standard Microsatellites in Relation to Prognosis in Metastatic Colorectal Cancer Patients

著者: Pirini, Francesca, Pasini, Luigi, Tedaldi, Gianluca, Scarpi, Emanuela, Marisi, Giorgia, Molinari, Chiara, Calistri, Daniele, Passardi, Alessandro, Ulivi, Paola
出版年 Int J Mol Sci (2020)

Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer

著者: Ulivi, Paola, Canale, Matteo, Passardi, Alessandro, Marisi, Giorgia, Valgiusti, Martina, Frassineti, Giovanni Luca, Calistri, Daniele, Amadori, Dino, Scarpi, Emanuela
出版年 Int J Mol Sci (2018)

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

著者: Maltoni Roberta, Nanni Oriana, Zumaglini Federica, Milandri Carlo, Gianni Lorenzo, Zoli Wainer, Massa Ilaria, Passardi Alessandro, Frassineti Giovanni, Amadori Dino
出版事項 2006-03-01

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

著者: Passardi, Alessandro, Massa, Ilaria, Zoli, Wainer, Gianni, Lorenzo, Milandri, Carlo, Zumaglini, Federica, Nanni, Oriana, Maltoni, Roberta, Frassineti, Giovanni Luca, Amadori, Dino
出版事項 2006

Prolonged Pemetrexed Infusion Plus Gemcitabine in Refractory Metastatic Colorectal Cancer: Preclinical Rationale and Phase II Study Results

著者: Passardi, Alessandro, Fanini, Francesca, Turci, Livia, Foca, Flavia, Rosetti, Paola, Ruscelli, Silvia, Casadei Gardini, Andrea, Valgiusti, Martina, Dazzi, Claudio, Marangolo, Maurizio
出版年 Oncologist (2017)

Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic Cancer

著者: Rapposelli, Ilario Giovanni, Casadei-Gardini, Andrea, Vivaldi, Caterina, Bartolini, Giulia, Bernardini, Laura, Passardi, Alessandro, Frassineti, Giovanni Luca, Massa, Valentina, Cucchetti, Alessandro
出版年 Biomolecules (2021)

miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer

著者: Molinari, Chiara, Salvi, Samanta, Foca, Flavia, Teodorani, Nazario, Saragoni, Luca, Puccetti, Maurizio, Passardi, Alessandro, Tamberi, Stefano, Avanzolini, Andrea, Lucci, Enrico, Calistri, Daniele
出版年 Onco Targets Ther (2016)

Radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of overall survival and recurrence-free survival

著者: Gardini, Andrea Casadei, Marisi, Giorgia, Canale, Matteo, Foschi, Francesco Giuseppe, Donati, Gabriele, Ercolani, Giorgio, Valgiusti, Martina, Passardi, Alessandro, Frassineti, Giovanni Luca, Scarpi, Emanuela
出版年 Onco Targets Ther (2018)

Low-dose taxotere enhances the ability of sorafenib to induce apoptosis in gastric cancer models

著者: Tesei, Anna, Leonetti, Carlo, Zupi, Gabriella, Scarsella, Marco, Brigliadori, Giovanni, Ulivi, Paola, Fabbri, Francesco, Arienti, Chiara, Amadori, Dino, Passardi, Alessandro, Silvestrini, Rosella, Zoli, Wainer
出版事項 2011

Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

著者: Zoli Wainer, Zumaglini Federica, Oliverio Giovanni, Pasquini Enzo, Dazzi Claudio, Dall'Agata Monia, Cecconetto Lorenzo, Passardi Alessandro, Nanni Oriana, Milandri Carlo, Frassineti Giovanni, Amadori Dino
出版事項 2008-10-01

Impact of Pre-Treatment Lactate Dehydrogenase Levels on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer

著者: Passardi, Alessandro, Scarpi, Emanuela, Tamberi, Stefano, Cavanna, Luigi, Tassinari, Davide, Fontana, Annalisa, Pini, Sara, Bernardini, Ilaria, Accettura, Caterina, Ulivi, Paola, Frassineti, Giovanni Luca, Amadori, Dino
出版年 PLoS One (2015)